Arecor Therapeutics revenue falls after Tetris Pharma operations cease
(Alliance News) - Arecor Therapeutics PLC on Monday said revenue fell in 2025 due to the end of operations at Tetris Pharma. Read More
| Price | 67.50p on 20-03-2026 at 18:50:05 |
|---|---|
| Change | -1.00p -1.46% |
| Buy | 70.00p |
| Sell | 65.00p |
| Last Trade: | Buy 15.00 at 70.00p |
| Day's Volume: | 8,086 |
| Last Close: | 67.50p |
| Open: | 68.50p |
| ISIN: | GB00BMWLM973 |
| Day's Range | 67.50p - 68.50p |
| 52wk Range: | 35.40p - 97.50p |
| Market Capitalisation: | £25.49m |
| VWAP: | 65.96741p |
| Shares in Issue: | 37.76m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Arecor Therape (AREC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 15 | 70.00p | SI Trade |
14:50:14 - 20-Mar-26 |
| Sell* | 2,896 | 65.00p | Ordinary |
14:10:09 - 20-Mar-26 |
| Buy* | 23 | 70.00p | Ordinary |
14:07:05 - 20-Mar-26 |
| Buy* | 23 | 72.00p | SI Trade |
14:07:05 - 20-Mar-26 |
| Sell* | 5,000 | 66.3417p | Ordinary |
14:06:53 - 20-Mar-26 |
| Buy* | 23 | 72.00p | Ordinary |
09:33:23 - 20-Mar-26 |
| Buy* | 23 | 72.00p | SI Trade |
09:33:23 - 20-Mar-26 |
| Buy* | 23 | 72.00p | Ordinary |
09:26:11 - 20-Mar-26 |
| Sell* | 20 | 65.00p | SI Trade |
09:26:11 - 20-Mar-26 |
| Buy* | 5 | 72.00p | SI Trade |
09:26:11 - 20-Mar-26 |
Arecor Therape (AREC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Mar 2026 7:00 am | RNS-R | Arecor to present at Oppenheimer conference |
| 9th Feb 2026 7:00 am | RNS | 2025 Business Update |
| 6th Jan 2026 2:01 pm | RNS | Fireside Panel Discussion on Diabetes sector |
| 9th Dec 2025 7:00 am | RNS | Arecor and Sequel Med Tech to host fireside panel |
| 17th Nov 2025 11:37 am | RNS | Holding(s) in Company |
| 11th Nov 2025 9:50 am | RNS | Holding(s) in Company |
| 4th Nov 2025 7:00 am | RNS | Enhanced IP Coverage: AT278 & Oral Peptide Program |
| 29th Sep 2025 7:00 am | RNS | Directorate Changes |
| 25th Sep 2025 7:00 am | RNS | Interim results for the six months to 30 June 2025 |
| 25th Sep 2025 7:00 am | RNS | Co-Development Agreement & Monetisation Deal |